Growth Metrics

Xtant Medical Holdings (XTNT) Other Accumulated Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Accumulated Expenses for 11 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 95.5% to $4.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.0 million, a 95.5% increase, with the full-year FY2024 number at $2.2 million, up 44.28% from a year prior.
  • Other Accumulated Expenses was $4.0 million for Q3 2025 at Xtant Medical Holdings, up from $3.8 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $4.2 million in Q1 2025 to a low of $800000.0 in Q2 2023.
  • A 5-year average of $1.8 million and a median of $1.4 million in 2021 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: plummeted 61.47% in 2021, then surged 213.05% in 2025.
  • Xtant Medical Holdings' Other Accumulated Expenses stood at $1.2 million in 2021, then dropped by 11.42% to $1.0 million in 2022, then surged by 48.16% to $1.5 million in 2023, then skyrocketed by 44.28% to $2.2 million in 2024, then surged by 81.23% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Other Accumulated Expenses are $4.0 million (Q3 2025), $3.8 million (Q2 2025), and $4.2 million (Q1 2025).